bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
WPI Micro Fine Mesh Baskets
WPI has introduced a series of Micro Fine Mesh Baskets that are suitable for washing or...
AdipoGen animal-free recombinant monoclonal antibodies (RecMAbs)
AdipoGen develops recombinant monoclonal antibodies (RecMAbs) without the use of animals. The...
Larodan research-grade natural and synthetic phospholipids
Larodan develops a comprehensive range of research-grade lipids for use as analytical standards...
